Tags: Drug.

Telavancin (trade name Vibativ) is a bactericidal lipoglycopeptide for use in MRSA or other Gram-positive infections. Telavancin is a semi-synthetic derivative of vancomycin.The FDA approved the drug in September 2009 for complicated skin and skin structure infections (cSSSI) and in June 2013 for hospital-acquired and ventilator-associated bacterial pneumonia caused by Staphylococcus aureus.

Telavancin.png
ATC prefix
J01
ATC suffix
XA03
CAS number
372151-71-8
ChEBI
71229
FDA UNII code
XK134822Z0
IUPAC name
(1S2R18R19R22S25R28R40S)-22-(2-Amino-2-oxoethyl)-515-dichloro-48-[2-O-(3-[2-(decylamino)ethyl]amino-236-trideoxy-3-methyl-α-(L)-lyxo-hexopyranosyl)-β-(D)-glucopyranosyl]oxy-218323537-pentahydroxy-19-[(N-methyl-(D)-leucyl)amino]-2023264244-pentaoxo-36-[(phosphonomethyl)amino]methyl-713-dioxa-2124274143-pentaazaoctacyclo[26.14.2.236.21417.1812.12933.01025.03439]pentaconta-358(48)911141629(45)30323436384649-pentadecaene-40-carboxylic acid
PubChem
3081362

Loading...

This page contains content from the copyrighted Wikipedia article "Telavancin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.